226 related articles for article (PubMed ID: 7858500)
1. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
Solary E; Bertrand R; Pommier Y
Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Bertrand R; Solary E; Jenkins J; Pommier Y
Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
[TBL] [Abstract][Full Text] [Related]
3. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors].
Solary E; Dubrez L; Eymin B; Bertrand R; Pommier Y
Bull Cancer; 1996 Mar; 83(3):205-12. PubMed ID: 8695922
[TBL] [Abstract][Full Text] [Related]
5. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
7. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
Del Bino G; Li X; Traganos F; Darzynkiewicz Z
Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535
[TBL] [Abstract][Full Text] [Related]
8. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.
Solary E; Bertrand R; Kohn KW; Pommier Y
Blood; 1993 Mar; 81(5):1359-68. PubMed ID: 8382972
[TBL] [Abstract][Full Text] [Related]
10. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
11. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.
Shou J; Ali-Osman F; Multani AS; Pathak S; Fedi P; Srivenugopal KS
Oncogene; 2002 Jan; 21(6):878-89. PubMed ID: 11840333
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
13. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
14. Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.
Sabisz M; Wesierska-Gadek J; Skladanowski A
Biochem Pharmacol; 2010 May; 79(10):1387-97. PubMed ID: 20067769
[TBL] [Abstract][Full Text] [Related]
15. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
16. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells.
Lansiaux A; Laine W; Baldeyrou B; Mahieu C; Wattez N; Vezin H; Martinez FJ; PiƱeyro A; Bailly C
Chem Res Toxicol; 2001 Jan; 14(1):16-24. PubMed ID: 11170504
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
19. Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.
Ling YH; Tseng MT; Nelson JA
Differentiation; 1991 Mar; 46(2):135-41. PubMed ID: 1648523
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]